These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20858720)
1. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Mazzoleni S; Politi LS; Pala M; Cominelli M; Franzin A; Sergi Sergi L; Falini A; De Palma M; Bulfone A; Poliani PL; Galli R Cancer Res; 2010 Oct; 70(19):7500-13. PubMed ID: 20858720 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Chakravarti A; Loeffler JS; Dyson NJ Cancer Res; 2002 Jan; 62(1):200-7. PubMed ID: 11782378 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446 [TBL] [Abstract][Full Text] [Related]
4. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells. Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625 [TBL] [Abstract][Full Text] [Related]
5. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration. Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604 [TBL] [Abstract][Full Text] [Related]
6. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294 [TBL] [Abstract][Full Text] [Related]
7. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility. Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694 [TBL] [Abstract][Full Text] [Related]
8. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019 [TBL] [Abstract][Full Text] [Related]
9. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. Shir A; Ogris M; Wagner E; Levitzki A PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410 [TBL] [Abstract][Full Text] [Related]
10. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982 [TBL] [Abstract][Full Text] [Related]
11. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Pandita A; Aldape KD; Zadeh G; Guha A; James CD Genes Chromosomes Cancer; 2004 Jan; 39(1):29-36. PubMed ID: 14603439 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498 [TBL] [Abstract][Full Text] [Related]
14. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM. Quezado M; Ronchetti R; Rapkiewicz A; Santi M; Blumenthal DT; Rushing EJ Clin Neuropathol; 2005; 24(4):163-9. PubMed ID: 16033132 [TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling. Kapoor GS; Kapitonov D; O'Rourke DM Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953 [TBL] [Abstract][Full Text] [Related]
18. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. Maity A; Pore N; Lee J; Solomon D; O'Rourke DM Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44. Liu FJ; Gui SB; Li CZ; Sun ZL; Zhang YZ Chin Med J (Engl); 2008 Sep; 121(17):1702-6. PubMed ID: 19024103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]